ABstrAct: Field effect in cancer, also called "field cancerization", attempts to explain the development of multiple primary tumors and locally recurrent cancer. The concept of field effect in cancer has been reinforced, since molecular alterations were found in tumoradjacent tissues with normal histopatho logical appearances. With the aim of investigating field effects in gastric cancer (GC), we conducted a highthroughput sequencing of the miRnome of four GC samples and their respective tumoradjacent tissues and compared them with the miRnome of a gastric antrum sample from patients without GC, assuming that tumoradjacent tissues could not be considered as normal tissues. The global number of miRNAs and read counts was highest in tumor sam ples, followed by tumoradjacent and normal samples. Analyzing the miRNA expression profile of tumoradjacent miRNA, were significantly downregulated compared with the antrum without tumor tissue (Pvalue , 0.01; foldchange ,5). Additionally, hsa-miR-3131, hsa-miR-664, and hsa-miR-150 were downregulated (Pvalue , 0.001) in all paired samples of tumor and tumoradjacent tissues, compared with antrum without tumor mucosa. The field effect was clearly demonstrated in gastric carcinogenesis by an epigeneticsbased approach, and potential biomarkers of the GC field effect were identified. The elevated expression of miRNAs in adjacent tissues and tumors tissues may indicate that a cascade of events takes place during gastric carcinogenesis, reinforcing the notion of field effects. This phenomenon seems to be linked to DNA methylation patterns in cancer and suggests the involvement of an epigenetic network mechanism.
Introduction
The field effect in cancer, also called "field cancerization", was first studied by Slaughter and Southwick 1 and attempts to explain the development of multiple primary tumors and locally recurrent cancer. According to this theory, precancer ous cells in proximity to tumors have some genetic fingerprints that are present in fully developed tumors. 2, 3 Recently, epige netic features, including DNA methylation, histone modifica tions, and miRNAs, have been described as early events in carcinogenesis. 4, 5 miRNAs play fundamental roles in multiple biological pro cesses, including cell proliferation, differentiation, and apop tosis. Altered miRNA expression levels may contribute to disease development in humans. 6, 7 The first characterized miRNAs were shown to be involved in cellular proliferation and death. Several reports link miRNAs to cancer. Human tumors and tumor cell lines exhibit large differences in miRNA expression levels compared with normal tissue. [7] [8] [9] miRNA expression patterns differ greatly between nor mal and cancer cells, and miRNAs are promising epigenetic biomarkers in cancer. 8 To understand the pattern of miRNA expression and to identify epigenetic molecular markers of field cancerization in noncancerous tissues, we performed high throughput sequencing of miRNAs (SOLiD ® platform) in paired samples of gastric adenocarcinomas and adjacent non cancerous tissue and compared the results to those of gastric mucosa.
Methods
Biological material. Four surgically resected gastric ade nocarcinomas were analyzed. Paired fresh samples of histologi cally proven cancer and noncancer samples were collected and clinical data collection. Clinical and anatomopatho logical data of patients were obtained directly from the records using the Lauren histological classification and staging according to the 7th edition of the pathological TNM staging (UICC/International Union Against Cancer).
ethics statement. The ethical principles of the Declara tion of Helsinki were followed, and written informed consent was obtained from all patients. The study was approved by the Research Ethics Committee of João Barros Barreto University Hospital (Hospital Universitário João Barros Barreto -HUJBB), Federal University of Pará (UFPA) (protocol num ber 14052004/HUJBB). mirNA library. Total small RNA was obtained from tissue samples using mirVana Isolation Kit (Ambion Inc., USA). Concentration and quality were determined using a Nanodrop 1000 spectrophotometer, and purification and size selection were performed using 6% polyacrylamide gel electro phoresis. Using SOLiD ® small RNA Expression Kit (Ambion Inc., USA), 200 ng of small RNA of 150-200 bp were used as template to obtain the miRNA library. All library miRNAs were tagged with unique and specific amplification prim ers, known as the barcode system (Life Technologies, CA, USA). Then, 50 pg of the library was pooled with seven other miRNA libraries at the same concentration. A fraction of the library pool (0.1 pg) was amplified and fixed on magnetic beads using emulsion PCR. The ePCR product was deposited on a single slide and subjected to multiplex SOLiD ® sequenc ing reaction. soLid ® ultra-deep sequencing and data analysis. The SOLiD ® (version 4.0) sequencing system (Life Technologies) was used to generate reads 35 bp long. The second step was to decode the barcodes, matching each bead sequence to the spe cific sample. All gastric tissues' small RNA sequences are avail able at European Nucleotide Archive under accession number ERP004687 and EMTAB2273. Sequence analyses were performed using SOLiD ® System Small RNA Analysis Tool (Life Technologies) and MiRanalyzer. 10 First, we filtered out all sequences that matched RNA contaminants such as tRNA, rRNA, DNA repeats, and adaptor molecules. After excluding contaminant reads, we aligned all sequences against miRNA precursor sequences using MirBase (version 19) and then included only reads that matched mature miRNA sequences.
11
mirNA qrt-Pcr (validation). To extract total RNA from each sample, High Pure miRNA Isolation Kit (Roche) was used, the solutions were quantified using the Qubit ® 2.0 Fluorometer (Invitrogen) and diluted to a final concentra tion of 4 ng/µL. Then cDNA was obtained using TaqMan ® MicroRNA Reverse Transcription Kit (Life Technologies), and qRTPCR was performed using the TaqMan ® MicroRNA Assays in RotorGene Q platform (Qiagen) with TaqMan miRNA assays according to the manufacturer's instructions (Life Technologies). The mean expression level of three human endogenous controls (Z30, RNU19, and RNU6B -calibra tors) was used as an internal control in all miRNA experi ments to allow for the comparison of expression results. The relative miRNA expression levels were then calculated by the comparative threshold cycle (Ct) method (2
−∆Ct
). data analysis. The betaBin model 12, 13 was used for dif ferential expression analysis and the results were presented as volcano plots. For these analysis R statistical environment was applied (http://www.rproject.org/). Our data was also compared to the expression data from other human neoplasia imported from microRNA.org database 14, 15 using a heatmap graphical analysis performed on GenePattern v.3.6.1 (http:// genepattern. broadinstitute.org).
Additionally, miRNA expression data from 436 samples were downloaded from The Cancer Genome Atlas (TCGA) stomach adenocarcinoma track. 16 These sample were com posed of 395 GC tissues and 41 GCadjacent tissues. The DESeq2 17 tool was used to compare these groups. For qRTPCR expression analysis, we applied the anal ysis of variance test to compare the miRNA expression lev els between GC, GCadjacent, and noncancer samples. The pairwise group differences were evaluated by Student's ttest adjusting for multiple testing using a Bonferroni's correction. All statistical tests were performed on IBM SPSS Statistics software (version 20).
results
After filtering for sequence Quality Value (minimum QV $10 for the first 10 bases) and performing an alignment with MirBase (version 19), 11 there were 148 mature miRNAs in antrum without tumor mucosa. 9 The number of mature miRNAs in the adjacent nontumor samples varied from 231 to 278, while in the tumor samples 245-372 miRNAs were expressed ( Table 1) .
The most highly expressed miRNAs were consistent among all the samples. The profiles of the 20 most highly expressed miRNAs in each group (normal, adjacent, and tumor) were compared to the available expression data from other tissues 18 ( Fig. 1) . Although we observed a consistent pattern among the most highly expressed miRNAs, many miRNAs were dif ferentially expressed (Pvalue , 0.001 and foldchange .5) when comparing the adjacent samples to antrum without tumor tissue. Among these miRNAs, hsa-miR-150, hsamiR-3131, hsa-miR-483, and hsa-miR-664a were exclusively downregulated in the tumoradjacent samples compared with the antrum without tumor tissue (Figs. 2 and 3) .
Similarly, some miRNAs were differentially expressed between paired adjacent and tumor samples (Pvalue , 0.001 and foldchange .5; Fig. 4) .
Compared with antrum without tumor mucosa, hsamiR-3131, hsa-miR-664, and hsa-miR-150 were downregu lated (Pvalue , 0.001) in all paired samples of tumor and tumoradjacent tissues ( Table 2 , Fig. 2) .
Additionally, some miRNAs were differentially expressed only in certain histological subtypes or specific TNM pre sentations, compared with antrum without tumor mucosa (Table 3) .
Many other miRNAs were specifically downregu lated in both tumor and tumoradjacent samples relative to antrum without tumor mucosa. These miRNAs included hsamiR-26a-1 and hsa-miR-212 in intestinal type T1N0M0, T1N1M0, and diffuse T1N1M0; hsa-miR-93, hsa-miR-3607, and hsa-miR-19b-1 in intestinal T1N0M0; hsa-miR-361 in intestinal T1N1M0s; hsa-miR-483 in intestinal T1N1M0 and T4N1M0; hsa-miR-204 in intestinal T4N1M0 and hsamiR-142 in diffuse T1N0M0 (Table 3) .
To evaluate the differential expression of hsa-miR-3131, hsa-miR-664, hsa-miR-150, and hsa-miR-483 between GC and GCadjacent tissues, we gather miRNA expression data of 436 samples (395 GC and 41 GCadjacent tissues) from TCGA stomach adenocarcinoma. 16 Among those samples, no significant expression difference was observed for those miRNA between the group, thus agreeing to our hypothesis of GC field effect.
qrt-Pcr. Our results for hsa-miR-3131, hsa-miR-664, hsa-miR-150, and hsa-miR-483 were validated by qRTPCR on 39 samples (21 noncancer, 4 GCadjacent, and 14 GC tissues). The hsa-miR-3131 presented too low expression in all samples precluding a more accurate analysis and prevent ing the translation of its use for future clinical practice. This result was in agreement with both our sequencing data and TCGA.
All other evaluated miRNAs (hsa-miR-664, hsa-miR-150, and hsa-miR-483) were differentially expressed on GCadja cent samples compared to noncancer samples (Pvalue # 0.05), while no significant difference was observed between GC and GCadjacent samples except for hsa-miR-483. Despite the fact that has-miR-150 presented an inverse expression profile in qRTPCR when compared to the sequencing, the results supported the hypothesis of GC field effect.
discussion
Most studies to date have compared tumor samples with adja cent nontumor samples to investigate genetic and epigenetic markers and expression patterns of diverse molecules. [19] [20] [21] This approach, while identifying many potential biological markers, has the bias of regarding tumoradjacent samples as normal samples. We compared normal tissue samples from noncancer patients to tumor and tumoradjacent samples in an integrated analysis and found significant differences between normal and tumoradjacent tissues (Fig. 2) , supporting the existence of field effects in cancer. Consequently, tumoradjacent samples should not be considered normal tissue.
The global number of miRNAs and read counts was highest in tumor samples, followed by tumoradjacent and normal samples. This phenomenon may indicate that a cascade of events takes place during gastric carcinogenesis, reinforcing the notion of field effects.
Our previous results also showed that a small number of miRNAs account for the majority of miRNA expression in tissues and can delineate tissue signatures. For example, the expression profile of less than 20 miRNAs defines antrum tissue, 9 and a similar situation exists for cardiac tissue. 22 These miRNAs are still expressed in tumoradjacent and tumor samples, although to a far less degree, forming an organ profile. Nevertheless, many other miRNAs seem to be differentially expressed in tumoradjacent and tumor samples. These data need to be analyzed from two different per spectives. The first involves looking at specific miRNAs that are differentially expressed among tissues and using them as biomarkers, or even targets, in clinical investigations. This seems to be the common approach but is rarely translated into clinical application. The second approach involves analyzing the entire data set as part of a biological process.
By looking at specific expression patterns, a number of findings were obtained. Some of these findings, as highlighted below, may be potential hallmarks of field effect in GC. The miRNAs hsa-miR-150, hsa-miR-3131, hsa-miR-483, and hsa-miR-664a are differentially expressed in every tumoradjacent sample compared to antrum without tumor. This group of miRNAs may indicate the occurrence of field effects in GC because differentiated expression of these reg ulatory molecules can provide a permissive environment for subsequent events in gastric carcinogenesis. In this context, the potential for clinical application seems high because screening of patients at risk for these markers can improve clinical management.
These miRNAs have been mentioned as biomarkers of a variety of tumors. 19, [21] [22] [23] [24] Here, we suggest that the simultane ous downregulation of these four miRNAs may be a marker of field effect in gastric carcinogenesis. It is important to note that this finding can only be proven by sequencing the com plete miRnome of normal gastric mucosa.
The hsa-miR-150, hsa-miR-483, and hsa-miR-664 were related to various types of cancers such as pancreatic, lung, bladder, leukemia, colorectal, breast, ovarian, hepatocellular, adrenocortical, esophageal, nasopharyngeal, squamous cell carcinoma, follicular lymphoma, prostate, and gastric. 23, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] The hsa-miR-150 available data indicate that this miRNA plays different roles depending on cell context due to its highly variable expression pattern. 41 Among the validated target genes, we highlight the TP53, 42 a major tumor suppres sor gene. It suggests an important role of hsa-miR-150 in the carcinogenesis process.
The hsa-miR-664 had been related to promoting tum origenesis and metastasis processes. 33 , 34 Patel et al found greater levels of hsa-miR-483 in patients with adrenal adenocarcinoma, 43 and Qiancheng Song et al reported that upregulation of hsa-miR-483 is correlated with the progression of human lung adenocarcinoma and promotes the epithelialmesenchymal transition accompanied by invasive and meta static properties of lung adenocarcinoma. 44 However, further functional studies are still necessary to explore the targets and the exact role of these miRNAs in cancer cell biology.
Based on our results, we propose that miRNA expres sion profiles are part of a general epigenetic phenomenon, possibly common to diverse biological situations. With respect to epigenetics and cancer methylation patterns, the comparison of normal versus cancer samples reveals a shift to global DNA hypomethylation and specific areas of hypermethylation. 5, [45] [46] [47] [48] According to this observation, the elevated expression of miRNAs in tumors and adjacent tissues should be linked to DNA methylation patterns in cancer (possibly with histone modification, expression of small RNAs, etc). In normal dif ferentiated tissue, a small number of specific transcripts are produced, and therefore, few miRNAs might be needed for the following steps of epigenetic control. In tumors, global DNA hypomethylation allows high levels of transcription (and also a reduction in specific transcripts). Consequently, the number of miRNAs significantly increases as part of a control mechanism (some are downregulated and linked to hypermethylation sites).
Globally, hypomethylation sites are distributed along regions of repetitive DNA and intronic and exonic regions. In addition to the production of cancerrelated transcripts and chromosomal instability, these regions promote miRNA tran scription, as most miRNAs are derived from these same areas. Most studies, including ours, address the expression patterns of specific miRNAs rather than a more general pro cess involving miRNA expression. Further validation of our concept and identification of the main players and controllers of this network could shed light on new epigenetic interfer ence strategies. Additionally, we propose that this epigenetic network might be a common mechanism in many biological conditions, such as proliferation, differentiation, and tissue regeneration.
conclusion
Using miRNA highthroughput data from normal gastric mucosa, nontumoradjacent tissue, and GC tissue, the field effect was clearly demonstrated in gastric carcinogenesis by an epigeneticsbased approach. Potential biomarkers of the GC field effect were also identified. Analysis of miRNA pro file findings versus the current concepts of cancer epigenet ics further suggests the involvement of an epigenetic network mechanism in cancer.
